相关实验视频

Updated: May 6, 2026

Real-Time Impedance-based Cell Analyzer as a Tool to Delineate Molecular Pathways Involved in Neurotoxicity and Neuroprotection in a Neuronal Cell Line

Real-Time Impedance-based Cell Analyzer as a Tool to Delineate Molecular Pathways Involved in Neurotoxicity and Neuroprotection in a Neuronal Cell Line

Published on: August 9, 2014

摩林和的保护作用对细胞胺诱导的神经毒性:一个多生物标志物方法

Hakan Bağ¹, Seval Yılmaz¹, Songül Çeribaşı²

¹Biochemistry Department, Firat University Veterinary Faculty, 23200, Elazig, Türkiye.

Open life sciences

|February 23, 2026

概括

莫林和提供神经保护,防止化疗副作用. 这些天然化合物对抗氧化应激和Cytarabine (Cyt) 诱导的亡,可能在接受癌症治疗的患者中减轻神经元损伤.

科学领域:

神经科学是一个神经科学.
药理学药理学是指药理学的学科.
生物化学生物化学

背景情况:

赛塔拉宾 (Cyt) 是急性髓性白血病 (AML) 和其他血液性癌症的重要化疗.
细胞诱导的神经毒性是一个重大的临床挑战,影响患者的生活质量.
了解Cyt诱导的神经毒性的机制对于开发有效的对策至关重要.

研究的目的:

为了研究莫林和的神经保护作用,以防止Cytarabine诱导的神经毒性.
阐明底层机制,重点关注氧化应激和亡途径.
评估这些天然化合物作为辅助疗法的潜力.

主要方法:

使用了一种老鼠模型,分组接受了对照剂,莫林, прополис,Cytarabine或组合剂.
生物化学测定测量了氧化应激标志物 (MDA,CAT,GSH-Px) 和亡标志物 (8-OHdG,Bax,Bcl-2,GPX4).
免疫组织化学和组织病理学检查评估了神经元损伤和蛋白质表达.

主要成果:

赛塔拉宾显著增加了氧化应激 (MDA升高,CAT/GSH-Px降低) 和亡 (8-OHdG/Bax增加,GPX4/Bcl-2减少).
摩林和 прополис治疗逆转了这些生化变化,减少了MDA和Bax,同时增加了抗氧化酶活性.
组织病理学分析证实,莫林和 прополис可以改善赛塔拉宾诱导的神经元损伤.

结论:

赛塔拉宾诱导的神经毒性是由氧化应激和亡介导的.
莫林和 прополис通过抵消这些机制,显示出显著的神经保护潜力.
这些发现表明,莫林和可以在管理化疗相关的神经毒性方面具有价值.

关键词:

灭症 (apoptosis) 是一种死亡的过程.细胞氨酸 (cytarabine) 是一种莫里恩·莫里恩是什么意思神经毒性的作用.普罗波利斯 (Propolis) 是一种植物.

更多相关视频

Protocol for the Differentiation of Human Induced Pluripotent Stem Cells into Mixed Cultures of Neurons and Glia for Neurotoxicity Testing

Protocol for the Differentiation of Human Induced Pluripotent Stem Cells into Mixed Cultures of Neurons and Glia for Neurotoxicity Testing

Published on: June 9, 2017

Assessing Neuroprotective Effects of Glycyrrhizae Radix et Rhizoma Extract Using a Transient Middle Cerebral Artery Occlusion Mouse Model

Assessing Neuroprotective Effects of Glycyrrhizae Radix et Rhizoma Extract Using a Transient Middle Cerebral Artery Occlusion Mouse Model

Published on: December 9, 2018

相关概念视频

Drugs Affecting Neurotransmitter Synthesis

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...

Antiepileptic Drugs: GABAergic Pathway Potentiators

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...

Anthelminthic Agents

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...